Questions

2972. Deputy Pat the Cope Gallagher asked the Minister for Health if she will remove the specific criteria of "insulin initiation from the start" that is preventing 500-700 people with a clinical diagnosis of type 1 diabetes from accessing continuous glucose monitoring (CGM) which clinical evidence overwhelmingly supports as the first-choice glucose monitoring device for all people with type 1 diabetes; and if she wi…

3019. Deputy Robert O'Donoghue asked the Minister for Health whether universal health insurance remains under consideration by the Government; and if she will make a statement on the matter. [25432/26]

3020. Deputy Robert O'Donoghue asked the Minister for Health if consideration will be given to introducing additional relief or supports for old age pensioners to assist with the rising cost of private health insurance premia; and if she will make a statement on the matter. [25434/26]

3050. Deputy Duncan Smith asked the Minister for Health her Department's position on oral immunotherapy as a food allergy treatment; whether the pilot programme in Cork will be expanded; and if she will make a statement on the matter. [25541/26]

3051. Deputy Duncan Smith asked the Minister for Health the grants available to a parent who currently would be forced abroad to ensure their child with a sesame allergy could receive oral immunotherapy; and if she will make a statement on the matter. [25542/26]

3098. Deputy Grace Boland asked the Minister for Health if she has considered appointing a dedicated clinical implementation lead to work across all maternity units to ensure that clinical guidelines under the National Maternity Strategy are being implemented consistently; and if she will make a statement on the matter. [25907/26]

3099. Deputy Grace Boland asked the Minister for Health if she is aware that women who experience two consecutive miscarriages are still reporting that they are not being referred for further investigation and what immediate actions will be taken to ensure maternity units comply with national guidance; and if she will make a statement on the matter. [25908/26]

3100. Deputy Grace Boland asked the Minister for Health if her Department will introduce a structured process to track the adoption of national maternity clinical guidelines in real time across all 19 maternity units on compliance guidance; and if she will make a statement on the matter. [25909/26]

3101. Deputy Grace Boland asked the Minister for Health if reporting has commenced from the six maternity units currently using the electronic health system on conditions such as early pregnancy loss, ectopic pregnancy, second-trimester loss and recurrent miscarriage; and if she will make a statement on the matter. [25910/26]

3102. Deputy Grace Boland asked the Minister for Health the way in which her Department intends to use the new eHealth system to close long-standing data gaps relating to women’s health, particularly early pregnancy loss, so that services, supports and research funding can be properly informed by accurate national data; and if she will make a statement on the matter. [25911/26]

3103. Deputy Grace Boland asked the Minister for Health whether standardised data definitions and reporting templates have been established for all maternity units ahead of full roll-out of the electronic health system, to ensure that critical women’s health data can be compared and aggregated nationally; and if she will make a statement on the matter. [25912/26]

3122. Deputy Roderic O'Gorman asked the Minister for Health for a detailed update in relation to the health diversion scheme for persons in possession of drugs for personal use; and if she will make a statement on the matter. [26009/26]

3177. Deputy Emer Currie asked the Minister for Health for an update on the development of a successor to the national maternity strategy; and if she will make a statement on the matter. [26314/26]

443. Deputy Michael Cahill asked the Minister for Health to introduce an Allergy Action Plan, including education and training to ensure that the use of epinephrine auto-injectors is properly addressed in schools as this is an important step in helping ensure that all children can have a safe and positive experience in school without the constant need to be on guard; and if she will make a statement on the matter. [2…

444. Deputy Michael Cahill asked the Minister for Health if she will consider that schools are often the first place where allergies are experienced and this is the reason relying on another child’s prescribed auto-injector is not a safe policy, therefore, every school should have its own emergency auto-injectors available to respond quickly when an unexpected reaction occurs; and if she will make a statement on the …

465. Deputy Michael Cahill asked the Minister for Health the steps being taken to introduce a universal healthcare system in Ireland; and if she will make a statement on the matter. [23305/26]

419. Deputy Aengus Ó Snodaigh asked the Minister for Health whether the National Dementia Strategy will be updated; the status of the National Dementia Strategy in relation to the Model of Care for Dementia; whether a full-term review is intended to be published following the 2018 Mid-Term Review; whether the National Dementia Strategy Monitoring Group are presently active; and if she will make a statement on the mat…

430. Deputy Malcolm Byrne asked the Minister for Health to outline her position on the use of AI scribes in healthcare; the current use and safeguards; and if she will make a statement on the matter. [23010/26]

440. Deputy Cathal Crowe asked the Minister for Health the main policy achievements of her Department since 22 January 2025; and if she will make a statement on the matter. [23079/26]

915. Deputy Donna McGettigan asked the Minister for Health for a progress report on the promised phased implementation of the Rheumatology Model of Care for Sjogren's Disease sufferers; whether the promised increase in the number of consultant rheumatologists, advanced nurse practitioners (ANPs) and allied health/health and social care professionals (HSCPs) providing rheumatology services has been completed, especial…

952. Deputy Ken O'Flynn asked the Minister for Health if she is aware of the barriers currently faced by patients in Ireland living with lipoedema, including the absence of a published national HSE care pathway, limited access to conservative management such as compression therapy and manual lymphatic drainage, and delays or difficulties accessing treatment through the Cross Border Healthcare Directive; what steps he…

953. Deputy Ken O'Flynn asked the Minister for Health whether the HSE working group established in 2023 to develop a national care pathway for lipoedema has completed its work; when the pathway is expected to be published; and whether patient advocacy organisations, including the Lipoedema Support Network Ireland, will be included in the development and implementation of this pathway [22010/26]

954. Deputy Ken O'Flynn asked the Minister for Health if her Department intends to review the operation of private health insurers in relation to coverage for medically indicated liposuction procedures for lipoedema patients, in light of concerns regarding inconsistent decision-making, the use of criteria designed for lymphoedema rather than lipoedema, and practices that may result in patients being forced to rely on…

958. Deputy Brian Stanley asked the Minister for Health to address the barriers currently faced by patients in Ireland living with lipoedema, including the absence of a published national HSE care pathway; the limited access to conservative management such as compression therapy and manual lymphatic drainage; the delays or difficulties accessing treatment through the Cross Border Healthcare Directive; the steps her D…

959. Deputy Brian Stanley asked the Minister for Health if the HSE working group established in 2023 to develop a national care pathway for lipoedema has completed its work; when the pathway is expected to be published; and whether patient advocacy organisations, including an organisation (details supplied), will be included in the development and implementation of this pathway. [22049/26]